These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1725576)

  • 1. Standardization of immunoassays.
    Masseyeff RF
    Ann Ist Super Sanita; 1991; 27(3):427-36. PubMed ID: 1725576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoassay of cytokines and growth factors in biological fluids.
    Kopp W; Reynolds C; Ruscetti F
    Dev Biol Stand; 1999; 97():29-37. PubMed ID: 10463528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies and immunoassays.
    Madersbacher S; Berger P
    Methods; 2000 May; 21(1):41-50. PubMed ID: 10764605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of serum testosterone in women; what should we do?
    Kane J; Middle J; Cawood M
    Ann Clin Biochem; 2007 Jan; 44(Pt 1):5-15. PubMed ID: 17270086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays.
    Ekins R; Chu F; Micallef J
    J Biolumin Chemilumin; 1989 Jul; 4(1):59-78. PubMed ID: 2801243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?
    Reber G; Boehlen F; de Moerloose P
    Semin Thromb Hemost; 2008 Jun; 34(4):340-6. PubMed ID: 18814067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of hapten immunoprocedures: total cortisol.
    Gosling JP; Middle J; Siekmann L; Read G
    Scand J Clin Lab Invest Suppl; 1993; 216():3-41. PubMed ID: 8378749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of labeled and unlabeled antibody enables self-calibration and reduction of sample matrix effects in immunoassay.
    Glass TR; Ohmura N; Saiki H; Lackie SJ
    Anal Biochem; 2004 Aug; 331(1):68-76. PubMed ID: 15245998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical aspects of thyroid antibodies estimation.
    Sinclair D
    Autoimmunity; 2008 Feb; 41(1):46-54. PubMed ID: 18176864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of immunoassays for hapten analytes.
    Gosling JP
    Scand J Clin Lab Invest Suppl; 1991; 205():95-104. PubMed ID: 1947754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein assays: standardization and quality control.
    Marcovina SM; Albers JJ
    Scand J Clin Lab Invest Suppl; 1990; 198():58-65. PubMed ID: 2111937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.
    Hursting MJ; Slaughter TF; Stead AG; Szewczyk KM; Witt DJ; Greenberg CS
    Arch Pathol Lab Med; 1998 Jan; 122(1):31-6. PubMed ID: 9448013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems with GH assays and strategies toward standardization.
    Bidlingmaier M
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S41-4. PubMed ID: 18819944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials.
    Panteghini M; Linsinger T; Wu AH; Dati F; Apple FS; Christenson RH; Mair J; Schimmel H
    Clin Chim Acta; 2004 Mar; 341(1-2):65-72. PubMed ID: 14967160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traceability and standardization of immunoassays: a major challenge.
    Morris HA
    Clin Biochem; 2009 Mar; 42(4-5):241-5. PubMed ID: 19863913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selected history and future of immunoassay development and applications in clinical chemistry.
    Wu AH
    Clin Chim Acta; 2006 Jul; 369(2):119-24. PubMed ID: 16701599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.